My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Opening of Bids - 2025 Curb and Sidewalk Program Proj No 125-001 - Premium Services
sbend
>
Public
>
Public Works
>
Board of Works Documents
>
2025
>
Opening of Bids
>
Opening of Bids - 2025 Curb and Sidewalk Program Proj No 125-001 - Premium Services
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/27/2025 2:12:43 PM
Creation date
5/27/2025 2:11:01 PM
Metadata
Fields
Template:
Board of Public Works
Document Type
Projects
Document Date
5/27/2025
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
111
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
Show annotations
View images
View plain text
Random testing will occur on a quarterly basis. Prior to selection, the DER shall ensure that the random testing pool <br />has been updated to include all current covered employees in the Company's workforce. The number of tests to <br />be conducted will be based on the number of covered employees at the beginning of each quarter's test cycle. <br />The DER, or C/TPA, shall use the random selection procedures to compile a list of covered employees selected <br />for testing in each testing cycle. The number of employees selected shall be sufficient to assure that the <br />minimum number of required tests can be achieved. The list of employees selected will be retained by the DER <br />n a secure location until the time of testing when the list will be provided to the appropriate division manager, <br />department head, or supervisor who will, in turn, notify the employee(s) to report for testing. <br />Random testing is unannounced, with employees being notified that they have been selected for testing after <br />they have reported for duty on the day of collection. Specimen collection will be conducted on different days of the <br />week throughout each test cycle to prevent employees from matching their drug use patterns to the schedule for <br />collection. Random tests are normally unobserved by the collector, However, provisions will be available at the <br />collection site for a directly observed collection to take place should circumstances require such action. <br />Once notified by the appropriate Company official, employees will be instructed to report immediately to the <br />collection site. <br />Reasonable Suspicion/Cause Testing. The Company will conduct reasonable suspicion testing, also known as <br />reasonable cause testing, based on the Company's observation of "signs and symptoms" of specific, <br />contemporaneous, articulable observations concerning the appearance, behavior, speech or body odors of the <br />employee. At least two Company supervisors, one of whom is trained in detection of the possible signs and <br />symptoms of drug use, shall substantiate and concur in the decision to test an employee. The concurrence <br />between the two supervisors may be by telephone. If the Company' has 50 or fewer employees subject to testing <br />under PHMSA regulations, only one supervisor, trained in detecting, possible drug use signs and symptoms, is <br />needed to make the decision to test. <br />The supervisor making the determination to test shall document, in writing, the behavioral signs and symptoms <br />that support the determination to conduct a reasonable suspicion/cause test. This documentation of the <br />employee's conduct shall be prepared and signed within 24 hours of the observed behavior or before the results of <br />the test are released, whichever is earlier. Refer to Appendix G- Reasonable Cause/Suspicion Observation <br />Checklist. The potentially affected employee should not be allowed to proceed alone to or from the collection site. <br />In addition to the safety concerns for the employee, ;accompanying the employee also assures that there is no <br />opportunity in route to the collection site for the employee to compromise the test through any method of tampering <br />that could affect the outcome 'of' the test results, Reasonable suspicion/cause tests are normally unobserved <br />by the collector. However, provisions will be available at the collection site for a directly observed collection to <br />take place should circumstances require such action. <br />The employee shall not perform a covered function pending the receipt of the drug test results. The employee <br />should make arrangements to be transported home The employee should be instructed not to drive any motor <br />„eki,.lo al is in fhP raasnnable belief that the employee maV be under the influence of a drug If the employee insists <br />Return-to•Duty Testing. The Company will conduct areturn-to-duty test prior to an employee returning to covered <br />safety -sensitive duty following a DOT violation. When an employee has a DOT violation the employee cannot work <br />again in any DOT covered safety -sensitive function until successfully completing the Substance Abuse <br />Professional (SAP) return -to -duty requirements. Only after the SAP has reported to the Company that the employee <br />s eligible to return to covered safety -sensitive duties is the Company authorized to return the employee to a <br />covered function. However, whether or not to do so is a business decision of the Company, not the DOT. <br />When the Company makes the decision to return the employee to covered safety -sensitive duty, the Company <br />will initiate the order for the return -to -duty test. All return -to-duty tests will be conducted using direct -observation <br />collection procedures. <br />Premium Concrete Services, Inc.- PHMSA DRUGIALCOHOL PLAN <br />20 <br />(' NATIONAL COMPnANCE MANAGEMENT SERVICE. INC. (NGMSI2D1 I (update 20211. 1'I,o NChIS Elan is <br />the suD�acl Dt n reyialerue capytlgl,l etlD Is DrolurteU by copynghl letra In the U S arvJ alsavrl,ele. All ri9Dls <br />eserve. <br />
The URL can be used to link to this page
Your browser does not support the video tag.